Through brain games, surveys and wearable technology, the VCU School of Nursing is studying how physical movement could be an indicator of dementia and serve as a roadmap for earlier interventions.
VCU research is developing new nonaddictive painkillers and re-engineering treatments to better care for opioid users.
The main ingredient in Ozempic has been found in landmark VCU-led clinical trials to stop and reverse fatty liver disease.
VCU and VCU Health have kicked off Unlocking Potential: VCU’s Campaign for the Future, a record-breaking $1.838 billion initiative, the most significant fundraising effort in the enterprise’s history.
Novel molecules discovered and built by VCU School of Pharmacy researchers may hold the key to new and more effective treatments for Alzheimer’s disease.
Research at VCU’s liver institute is deepening an understanding of the liver’s surprising connection to cognitive health and testing new treatments to confront a growing global health issue.
The Massey-led Winn Awards program offers tools to develop and implement clinical trials that lead to better outcomes for all.
VCU Massey Comprehensive Cancer Center researchers are developing new ways to better treat certain types of aggressive breast cancers.
VCU Health Hume-Lee Transplant Center researchers are developing a method to selectively target liver cancer cells using photodynamic therapy.
Philanthropically supported pilot grant awards are paving the way for scientists and physician researchers to complete early-stage studies for promising research.
The family of a beloved VCU School of Medicine faculty member is furthering their late patriarch’s mission through a foundation that supports much- needed addiction research.
Inspired by his mentor, the medical director of VCU Sports Medicine has created an endowed fund to honor Thomas Loughran, M.D., a VCU sports medicine G.O.A.T.
Your generosity inspires innovation, encourages excellence and transforms dreams into discoveries. Discover your great place in the VCU Health community.
Giving